Rheumatoid arthritis Musculoskeletal Diseases Rheumatoid arthritis
Conditions
Interventions
All participants will undergo four treatment phases each lasting for a period of five weeks in a randomised sequence. Participants will be asked to wear each of the four devices for a minimum of 12 h
Sponsors
The University of York (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years of age or over 2. Diagnosis of rheumatoid arthritis within medical records 3. Chronic pain: either persistent or intermittent over a minimum period of three months prior to recruitment 4. Current pain: greater than 30/100 mm on Visual Analogue Scale (VAS) within the last 24 hours despite medication
Exclusion criteria
Exclusion criteria: 1. Pregnancy 2. Pacemaker or similar device 3. Not responsible for administering his/her own medication. 4. Dementia or memory impairment, either documented in medical records or if suspected indicated by a score of six or below on the Abbreviated Mental Test 5. Diagnosis of malignant disease within medical records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain 2. Inflammation (using acute phase reactants as proxy measures) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Physical function 2. Disease activity 3. General health 4. Quality of life | — |
Countries
United Kingdom
Outcome results
None listed